Metabolic stimulation of mouse spleen lymphocytes by low doses of Δ9-tetrahydrocannabinol

Life Sciences

Volumn 60, Issue 19, 1997, Pages 1709-1717

  Sánchez, Cristina ^a   Velasco, Guillermo ^a   Guzmán, Manuel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

cannabinoids; glucose metabolism; lymphocytes

Indexed keywords

ANANDAMIDE; CANNABINOID CB1 RECEPTOR ANTAGONIST; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABIS; CARBON DIOXIDE; CYCLIC AMP; DEXANABINOL; DRONABINOL; FORSKOLIN; GLUCOSE; METHANANDAMIDE; PALMIDROL; PERTUSSIS TOXIN; PHOSPHOLIPID; RADIOISOTOPE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; MOUSE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; SPLEEN LYMPHOCYTE;

ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORSKOLIN; GLUCOSE; LYMPHOCYTES; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; PERTUSSIS TOXIN; PHOSPHOLIPIDS; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPLEEN; TETRAHYDROCANNABINOL; VIRULENCE FACTORS, BORDETELLA;

EID: 0343144861     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00113-6     Document Type: Article

References (40)

1. M.E. ABOOD and B.R. MARTIN, Trends Pharmacol. Sci. 13 201-206 (1992).
2. L.E. HOLLISTER, J. Psychoact. Drugs 24 159-164 (1992).
3. H. SCHWARTZ, F.J. BLANCO and M. LOTZ, J. Neuroimmunol. 55 107-115 (1994).
4. T.W. KLEIN, Y. KAWAKAWI, C. NEWTON and H. FRIEDMAN, J. Toxicol. Environ. Health 32 465-177 (1991).
5. J.L. TANG, G. LANCZ, S. SPECTER and H. BULLOCK, Int. J. Immunopharmacol. 14 253-262 (1992).
6. K.L. McCOY, D. GAINEY and G.A. CABRAL, J. Pharmacol. Exp. Ther. 273 1216-1223 (1995).
7. K. FISCHER-STENGER, D.A. DOVE PETTIT and G.A. CABRAL, J. Pharmacol. Exp. Ther. 267 1558-1565 (1993).
8. Y. NAKANO, S.H. PROSS and H. FRIEDMAN, Proc. Soc. Exp. Biol. Med. 201 165-168 (1992).
9. L.A. MATSUDA, S.J. LOLAIT, M. BROWNSTEIN, A. YOUNG and T.I. BONNER, Nature 346 561-564 (1990).
10. S. MUNRO, K.L. THOMAS and M. ABU-SHAAR, Nature 365 61-65 (1993).
11. A.C. HOWLETT, Annu. Rev. Pharmacol. Toxicol. 35 607-634 (1995).
12. S. GALIEGUE, S. MARY, J. MARCHAND, D. DUSSOSSOY, C. CARRIERE, P. CARAYON, M. BOUABOULA, D. SHIRE, G. LE FUR and P. CASELLAS, Eur. J. Biochem. 232 54-61 (1995).
13. L. FACCI, R. DAL TOSO, S. ROMANELLO, A. BURIANI, S.D. SKAPER and A. LEON, Proc. Natl. Acad. Sci. USA 92 3376-3380 (1995).
14. L. MURPHY and A. BARTKE, Neurobiology and Neurophysiology of Cannabinoids. Biochemistry and Physiology of Substance Abuse. CRC-Press, Boca Raton, FL, USA (1992).
15. D.M. SLIPETZ, G.P. O'NEILL, L. FACREAU, C. DUFRESNE, M. GALLANT, Y. GAREAU, D. GUAY, M. LABELLE and K.M. METTERS, Mol. Pharmacol. 48 352-361 (1995).
16. C.C. FELDER, K.E. JOYCE, E.M. BRILEY, J. MANSOURI, K. MACKI, O. BLOND, Y. LAY, A.L. MA and R.L. MITCHELL, Mol. Pharmacol. 48 443-450 (1995).
17. M.S.M. ARDAWY and E.A. NEWSHOLME, Essays Biochem. 21 1-43 (1985).
18. P.C. CALDER, P. YAQOOB, D.J. HARVEY, A. WATTS and E.A. NEWSHOLME. Biochem. J. 300 509-518 (1994).
19. S. JACKOWSKI, J. Biol. Chem. 271 20219-20222 (1996).
20. M. GUZMAN and J. CASTRO, Biochem. J. 264 107-113 (1989).
21. J.M. DEROQ, M. SEGUI, J. MARCHAND, G. LE FUR and P. CASELLAS, FEBS Lett. 369 177-182 (1995).
22. M. RINALDI-CARMONA, F. BARTH, M. HEAULME, D. SHIRE, B. CALANDRA, C. CONGY, S. MARTINEZ, J. MARUANI, G. NELIAT, D. CAPUT, P. FERRARA, J.C. SOUBRIE, J.C. BRELIERE and G. LE FUR, FEBS Lett. 350 240-244 (1994).
23. R. MECHOULAM, L. HANUS and B.R. MARTIN, Biochem. Pharmacol. 48 1537-1544 (1994).
24. V. DI MARZO, L. DE PETROCELLIS, T. BISOGNO and S. MAURELLI, J. Drug. Dev. Clin. Pract. 7, 199-219 (1995).
25. M. GUZMAN, G. VELASCO and J. CASTRO, Am. J. Physiol. 270 G701-G707 (1996).
26. V. DI MARZO, L. DE PETROCELLIS, N. SEPE and A. BUONO, Biochem. J. 316 977-984 (1996).
27. M. BAYEWITCH, T. AVIDOR-REISS, R. LEVY, J. BARG, R. MECHOULAM and Z. VOGEL, FEBS Lett. 375 143-147 (1995).
28. M. BAYEWITCH, M.H. RHEE, T. AVIDOR-REISS, A. BREUER, R. MECHOULAM and Z. VOGEL, J. Biol. Chem. 271 9902-9905 (1996).
29. M. BOUABOULA, C. POINOT-CHAZEL, B. BOURRIE, X. CANAT, B. CALANDRA, M. RINALDI-CARMONA, G. LE FUR and P. CASELLAS, Biochem. J. 312 637-641 (1995).
30. M. BOUABOULA, B. BOURRIE, M. RINALDI-CARMONA, D. SHIRE, G. LE FUR and P. CASELLAS, J. Biol. Chem. 270 13973-13980 (1995).
31. D. SHIRE, B. CALANDRA, M. RINALDI-CARMONA, D. OUSTRIC, B. PESSEGUE, O. BONNIN-CABANNE, G. LE FUR, D. CAPUT and P. FERRARA, Biochim. Biophys. Acta 1307 132-136 (1996).
32. M. BOUABOULA, C. POINOT-CHAZEL, J. MARCHAND, X. CANAT, B. BOURRIE, M. RINALDI-CARMONA, B. CALANDRA, G. LE FUR and P. CASELLAS, Eur. J. Biochem. 237 704-711 (1996).
33. N.E. KAMINSKI, Biochem. Pharmacol. 52 1133-1140 (1996).
34. G.R. POST and J.H. BROWN, FASEB J. 10 741-749 (1996).
35. D. BURNETTE-CURLEY and G.A. CABRAL, Proc. Soc. Exp. Biol. Med. 210 64-76 (1995).
36. S.R. CHILDERS and S.A. DEADWYLER, Biochem. Pharmacol. 52 819-827 (1996).
37. E. FRIDE, J. BARG, R. LEVY, D. SAYA, E. HELDMAN, R. MECHOULAM and Z. VOGEL, J. Pharmacol. Exp. Ther. 272 699-707 (1995).
38. D.W. PATE, K. JARVINEN, A. URTTI, P. JARHO and T. JARVINEN, Curr. Eye Res. 14 791-797 (1995).
39. K. VARGA, K. LAKE, B.R. MARTIN and G. KUNOS, Eur. J. Pharmacol. 278 279-283 (1995).
40. L. GRINSPOON and J.B. BAKALAR, JAMA 273 1875-1876 (1995).